OTCMKTS:CHEOF Cochlear (CHEOF) Stock Price, News & Analysis $217.00 0.00 (0.00%) (As of 06/28/2024 ET) Add Compare Share Share Today's Range$217.00▼$217.0050-Day Range$204.04▼$219.9652-Week Range$145.73▼$230.46VolumeN/AAverage Volume189 shsMarket CapitalizationN/AP/E Ratio132.16Dividend Yield0.59%Price TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get Cochlear alerts: Email Address Ad The Freeport SocietyBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. About Cochlear Stock (OTCMKTS:CHEOF)Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More CHEOF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHEOF Stock News HeadlinesJuly 26, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Cochlear Limited (OtherCHEOF)July 20, 2023 | msn.comChandy’s Cochlear Implant Scheme hits hurdles, parents seek government helpJuly 1, 2024 | The Freeport Society (Ad)Biden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.July 19, 2023 | benzinga.comSensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in EuropeJuly 18, 2023 | msn.com7-year-old girl hears for first time after Chhattisgarh govt sponsors operation, father wants her to become doctorJuly 18, 2023 | msn.comOommen Chandy: Humane leader who put patients first, say health expertsJuly 10, 2023 | markets.businessinsider.comMorgan Stanley Keeps Their Hold Rating on Cochlear Limited (CHEOF)July 10, 2023 | benzinga.comSensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UKJuly 1, 2024 | The Freeport Society (Ad)Biden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.July 5, 2023 | benzinga.comSensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical StudyJune 25, 2023 | msn.comRajasthan: Govt announces ₹1 lakh airfare for travel for organ transplantJune 25, 2023 | thetimes.co.ukNHS may have missed thousands of deaf children in ‘huge national failure’June 22, 2023 | morningstar.comFTSE 100 Closes Down 0.75% After Rate Hike; Ocado Surges on Bid SpeculationJune 22, 2023 | afr.comLabor bows to pressure on multinational tax disclosureJune 19, 2023 | finance.yahoo.comSensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical StudyMay 22, 2023 | afr.com‘Next Cochlear’ stock surges after heart device breakthroughMay 4, 2023 | marketwatch.comCochlear Implants Market Share | Business till 2030May 3, 2023 | msn.comParents to inform SA cochlear implant reviewApril 20, 2023 | msn.comTownsville University Hospital staff stood down amid review of paediatric audiology unit outcomesApril 16, 2023 | afr.comAustralian business delegation heads to ChinaApril 11, 2023 | msn.comSurgeries of chronically ill children in Pune pending under RBSKApril 6, 2023 | marketwatch.comCochlear Implant (CI) Systems Market 2023-2030| Expert Analysis of Current Trend and Scope to Drive the MarketApril 6, 2023 | marketwatch.comSensorion Announces Candidate Selection for GJB2 Gene Therapy ProgramMarch 22, 2023 | uk.news.yahoo.comDad runs half marathon to help deaf babies like his sonMarch 22, 2023 | nasdaq.comCochlear, Demant contest UK regulator's Oticon deal concernsMarch 21, 2023 | markets.businessinsider.comDr. Jace Wolfe named Senior Vice President at Oberkotter Foundation - Hearing FirstMarch 13, 2023 | afr.comThis company found the miracle cancer cure – then dropped itSee More Headlines Receive CHEOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:CHEOF CUSIPN/A CIK1453930 Webwww.cochlear.com Phone(129) 428-6555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio132.16 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Diggory William Howitt BE (Hons) (Age 57)MBA, CEO, MD, President & Executive Director Comp: $3.2MMr. Stuart SayersChief Financial OfficerMr. Jan Janssen MSc Elec Eng (Age 59)Chief Technology Officer Comp: $1.36MMs. Karen O'DriscollChief Information OfficerMs. Kristina DevonVice President of Investor RelationsMr. Rob McGroryGroup General Counsel & Company SecretaryMs. Jennifer StevensonVP of Corporate Communications & BrandMr. Dean PhizackleaSenior Vice President of Global Strategic MarketingMs. Jennifer HornerySenior Vice President of Global People & CultureMr. Greg Bodkin BE (Hons)MComm (UNSW), Senior Vice President of Global Supply ChainMore ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors CHEOF Stock Analysis - Frequently Asked Questions How have CHEOF shares performed in 2024? Cochlear's stock was trading at $198.50 at the beginning of the year. Since then, CHEOF stock has increased by 9.3% and is now trading at $217.00. View the best growth stocks for 2024 here. Are investors shorting Cochlear? Cochlear saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 122,900 shares, an increase of 7.4% from the May 31st total of 114,400 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 1,229.0 days. View Cochlear's Short Interest. Is Cochlear a good dividend stock? Cochlear (OTCMKTS:CHEOF) pays an annual dividend of $1.27 per share and currently has a dividend yield of 2.07%. The dividend payout ratio is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable. How do I buy shares of Cochlear? Shares of CHEOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CHEOF) was last updated on 7/1/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | Sponsored270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredWho is Investor X and why are they betting big on nickel?Nickel is fast becoming one of the most important - and most valuable - commodities today. It's essential f...The Tomorrow Investor | SponsoredA new pathway to wealth was born inside my wine-cellarThese days, the “right” to receive a welfare check enjoys greater popularity than the right to make a living. ...Porter & Company | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredThe End of Privacy for Americans… Get Out of Cash Now!Unlock the Secret to Outsmarting Inflation with "The Trump Loophole" That investment? Gold.Golden Crest | SponsoredWill Biden Be Replaced?There are growing rumors of a possible Joe Biden replacement following his first debate against Donald Trump. ...Stansberry Research | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cochlear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
